Relationship Between ACE2 and Other Components of the Renin-Angiotensin System.

Angiotensin receptor blockers Angiotensin-converting enzyme Angiotensin-converting enzyme inhibitors COVID-19 Cardiovascular disease Chronic kidney disease Coronavirus infections Hypertension Renin-angiotensin system

Journal

Current hypertension reports
ISSN: 1534-3111
Titre abrégé: Curr Hypertens Rep
Pays: United States
ID NLM: 100888982

Informations de publication

Date de publication:
26 06 2020
Historique:
entrez: 28 6 2020
pubmed: 28 6 2020
medline: 9 7 2020
Statut: epublish

Résumé

Angiotensin-converting enzyme 2 (ACE2) is a key counter-regulatory component of the renin-angiotensin system. Here, we briefly review the mechanistic and target organ effects related to ACE2 activity, and the importance of ACE2 in SARS-CoV-2 infection. ACE2 converts angiotensin (Ang) II to Ang-(1-7), which directly opposes the vasoconstrictive, proinflammatory, and prothrombotic effects of Ang II. ACE2 also facilitates SARS-CoV-2 viral entry into host cells. Drugs that interact with the renin-angiotensin system may impact ACE2 expression and COVID-19 pathogenesis; however, the magnitude and direction of these effects are unknown at this time. High quality research is needed to improve our understanding of how agents that act on the renin-angiotensin system impact ACE2 and COVID-19-related disease outcomes.

Identifiants

pubmed: 32591908
doi: 10.1007/s11906-020-01048-y
pii: 10.1007/s11906-020-01048-y
pmc: PMC7317893
mid: NIHMS1607741
doi:

Substances chimiques

Receptors, Virus 0
Peptidyl-Dipeptidase A EC 3.4.15.1
ACE2 protein, human EC 3.4.17.23
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

44

Subventions

Organisme : NHLBI NIH HHS
ID : T32 HL007891
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL133843
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL146818
Pays : United States
Organisme : NHLBI NIH HHS
ID : K01 HL133468
Pays : United States
Organisme : NHLBI NIH HHS
ID : L40 HL148910
Pays : United States
Organisme : NIDDK NIH HHS
ID : UC4 DK108173
Pays : United States

Références

JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Adv Intern Med. 2000;45:419-29
pubmed: 10635057
Hypertension. 2010 Jan;55(1):90-8
pubmed: 19948988
Europace. 2017 Aug 1;19(8):1280-1287
pubmed: 27738071
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Circulation. 2010 Aug 17;122(7):717-28, 18 p following 728
pubmed: 20679547
Am J Physiol Heart Circ Physiol. 2020 May 1;318(5):H1084-H1090
pubmed: 32228252
Metabolism. 2019 Jun;95:36-45
pubmed: 30905634
Circ Res. 2016 Apr 15;118(8):1313-26
pubmed: 27081112
Hypertension. 2019 Apr;73(4):829-838
pubmed: 30739537
Sci Rep. 2016 Jan 27;6:19840
pubmed: 26813885
PLoS One. 2018 Jun 13;13(6):e0198144
pubmed: 29897923
JAMA Cardiol. 2020 Jul 1;5(7):831-840
pubmed: 32219363
Hypertension. 2006 Nov;48(5):914-20
pubmed: 17000927
Am J Pathol. 2007 Aug;171(2):438-51
pubmed: 17600118
Compr Physiol. 2014 Jul;4(3):1201-28
pubmed: 24944035
Am J Hypertens. 2002 Jan;15(1 Pt 2):3S-8S
pubmed: 11824873
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Diabetes. 2010 Feb;59(2):529-38
pubmed: 19934006
Am J Physiol Cell Physiol. 2007 Jan;292(1):C82-97
pubmed: 16870827
Nephrol Dial Transplant. 2013 Nov;28(11):2687-97
pubmed: 23956234
Hypertension. 2014 Dec;64(6):1368-1375
pubmed: 25225202
Kidney Int. 2007 Sep;72(5):614-23
pubmed: 17579661
Hypertension. 2012 Feb;59(2):300-7
pubmed: 22184331
Endocrinology. 2007 May;148(5):2453-7
pubmed: 17303661
Thromb Res. 2016 Feb;138:114-120
pubmed: 26709040
Hypertension. 2004 May;43(5):970-6
pubmed: 15007027
Circ Res. 2000 Sep 1;87(5):E1-9
pubmed: 10969042
Clin Sci (Lond). 2019 Jan 8;133(1):55-74
pubmed: 30622158
Nature. 2005 Jul 7;436(7047):112-6
pubmed: 16001071
Clin J Am Soc Nephrol. 2020 May 7;15(5):714-716
pubmed: 32220930
Circulation. 2005 May 24;111(20):2605-10
pubmed: 15897343
Hypertension. 2006 Oct;48(4):572-8
pubmed: 16908757
Am J Physiol Renal Physiol. 2009 Feb;296(2):F398-405
pubmed: 19004932
Nat Med. 2005 Aug;11(8):875-9
pubmed: 16007097
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
Biochemistry. 2003 Nov 18;42(45):13185-92
pubmed: 14609329

Auteurs

Jordana B Cohen (JB)

Renal-Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jco@pennmedicine.upenn.edu.
Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jco@pennmedicine.upenn.edu.

Thomas C Hanff (TC)

Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Division of Cardiology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Adam P Bress (AP)

Division of Health System Innovation and Research, Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA.

Andrew M South (AM)

Section of Nephrology, Department of Pediatrics, Wake Forest School of Medicine and Brenner Children's Hospital, Winston Salem, USA.
Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest School of Medicine, Winston Salem, USA.
Department of Surgery-Hypertension and Vascular Research, Wake Forest School of Medicine, Winston Salem, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH